Cervical Screening-2 (PAP Smear and HPV-DNA) LBC
54+ booked in last 3 daysOverview
Human Papillomavirus (HPV) is a group of viruses, some causing warts, and others associated with various health concerns like cervical cancer. It is a prevalent infection, and preventive measures, such as vaccination, are essential for managing its impact on public health. Cervical Screening-2, incorporating PAP Smear and HPV-DNA testing with Liquid-Based Cytology (LBC), is a vital strategy in addressing the multifaceted health risks associated with Human Papillomavirus (HPV). This approach combines the examination of cervical cells for abnormalities (PAP Smear) with the identification of high-risk HPV strains (HPV-DNA testing) and employs Liquid-Based Cytology for improved sample collection and analysis accuracy. Cervical Screening-2 is instrumental in early detection, facilitating timely intervention, and preventive measures against HPV-related health issues.
Cervical Screening-2 (PAP Smear and HPV-DNA) LBC Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Cervical Screening-2 (PAP Smear and HPV-DNA) LBC with a clear pricing structure.
The Cervical Screening-2 (PAP Smear and HPV-DNA) LBC Price in Mumbai is ₹ 3,300 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
This test measures two important aspects:
- PAP Smear: It examines cells collected from the cervix for any abnormal changes that could indicate pre-cancerous or cancerous conditions.
- HPV-DNA: It identifies the presence of high-risk strains of HPV, which can increase the risk of developing cervical cancer.
This test is performed for various reasons, including:
- Early detection of pre-cancerous or cancerous changes in the cervix
- Screening for high-risk HPV infections, which can lead to cervical cancer
- Monitoring the effectiveness of treatment for cervical cancer or pre-cancerous conditions
- Assessing the need for further diagnostic procedures or interventions
Your doctor may recommend this test if you:
- Are a woman aged 21 years or above
- Have never had a PAP smear before
- Have a history of abnormal PAP smear results
- Have been previously diagnosed with cervical cancer or pre-cancerous cervical conditions
Abnormal results may indicate the presence of pre-cancerous or cancerous changes in the cervix or a high-risk HPV infection. However, abnormal results do not necessarily mean that you have cervical cancer. Further evaluation and diagnostic tests may be required. Discussing your results with your doctor is crucial for accurate interpretation.
During the test:
- A healthcare professional will collect cells from your cervix using a special brush or spatula.
- The sample will be analysed in a laboratory using the Liquid-Based Cytology (LBC) technique, which provides more accurate results.
- The presence of abnormal cells or high-risk HPV strains will be determined.
To prepare for the test:
- Schedule the test when you are not menstruating.
- Avoid using tampons, vaginal medications, lubricants, or douches for at least two days before the test.
- Inform your doctor about any vaginal infections or recent sexual activity.
- Follow any additional instructions provided by your doctor/healthcare provider.
Additional tests that may be recommended include:
- Colposcopy: A procedure to closely examine the cervix for abnormal areas
- Biopsy: Removal of a small tissue sample from the cervix for further examination
- Cone biopsy or loop electrosurgical excision procedure (LEEP): Removal of a cone-shaped piece of tissue from the cervix for diagnostic or therapeutic purposes
- PAP Smear with HPV-DNA Test
- Cervical Cancer Screening Test
- Liquid-Based Cytology (LBC) with HPV Testing
Cervical cancer is a type of cancer that develops in the cells of the cervix. It usually starts with pre-cancerous changes that may progress to cancer if left untreated. Risk factors include HPV infection, smoking, a weakened immune system, and a family history of cervical cancer. Regular screenings can help detect cervical cancer at an early stage when it's most treatable.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.